Citizens Capital Markets served as the exclusive financial advisor to Trigon Holding in the sale of substantially all of the assets of StelKast to Globus Medical.
Founded in 1992 and headquartered in McMurray, PA, StelKast designs, manufactures and distributes a full line of orthopedic implants for knee and hip replacement systems and surgical instrumentation systems. _x000D_
_x000D_
“We are proud to have advised Trigon on the divestiture of StelKast,” said Citizens Managing Director Matt Mueller, who led the transaction with Ralph M. Della Ratta, co-head of M&A Advisory. “With the robust resources Globus will provide, Stelkast is well-positioned for continued growth and innovation and we look forward to watching their future success.”
